Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients-Reference-Cited by-同舟云学术

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

Published:2014-05-16 Issue:8 Volume:89 Page:E121-E124
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Tefferi Ayalew¹,Wassie Emnet A.¹,Guglielmelli Paola²,Gangat Naseema¹,Belachew Alem A.¹,Lasho Terra L.¹,Finke Christy¹,Ketterling Rhett P.³,Hanson Curtis A.⁴,Pardanani Animesh¹,Wolanskyj Alexandra P.¹,Maffioli Margherita⁵,Casalone Rosario⁵,Pacilli Annalisa²,Vannucchi Alessandro M.²,Passamonti Francesco⁵

Affiliation:

1. Division of Hematology; Department of Medicine; Mayo Clinic; Rochester Minnesota

2. Laboratorio Congiunto MMPC; Department of experimental and clinical medicine; University of Florence; Florence Italy

3. Division of Cytogenetics; Mayo Clinic; Rochester Minnesota

4. Division of Hematopathology; Mayo Clinic; Rochester Minnesota

5. Division of Hematology; Genetic Unit, Medical Genetic and Cytogenetics Laboratory, SSD, SMEL, University Hospital Ospedale di Circolo e Fondazione Macchi; Varese Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23743/fullpdf

Reference18 articles.

1. Somatic mutations of calreticulin in myeloproliferative neoplasms;Klampfl;N Engl J Med,2013

2. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2;Nangalia;N Engl J Med,2013

3. Genetics: CALR mutations and a new diagnostic algorithm for MPN;Tefferi;Nat Rev Clin Oncol,2014

4. Tefferi A Lasho TL Finke CM

5. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes;Rumi;Blood,2013

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Pathology of Myeloid Neoplasms;Clinics in Laboratory Medicine;2024-06

2. The characteristics of CALR mutations in myeloproliferative neoplasms: a clinical experience from a tertiary care center in Qatar and a literature review;Hematology;2024-05-28

3. CALR mutation burden in essential thrombocythemia and disease outcome;Blood;2024-03-28

4. Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients;Turkish Journal of Hematology;2024-03-04

5. One thousand patients with essential thrombocythemia: the Florence-CRIMM experience;Blood Cancer Journal;2024-01-18